SCHEMBL7678090

SCHEMBL7678090

COC(=O)c1cc(OC)cc2c1CCCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR5 P32302 1/20 0.44
KDM4E B2RXH2 6/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
GAA P10253 3/20 0.42
POLB P06746 3/20 0.42
HPGD P15428 3/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 4/20 0.40
RAB9A P51151 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GLA P06280 1/20 0.39
ATM Q13315 1/20 0.39
NPC1 O15118 3/20 0.39
ACHE P22303 3/20 0.39
ALDH1A1 P00352 3/20 0.38
HSD17B10 Q99714 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7681591 0.85 CXCR5 (0.48) CXCR5KDM4EPOLBHPGDMAPT
SCHEMBL7677714 0.84 CXCR5 (0.42) CXCR5KDM4EPOLBMAPTRAB9A
SCHEMBL27353130 0.83 PPARG (0.40) KDM4EPOLBHPGDMAPTRAB9A
SCHEMBL30995649 0.82 CA12 (0.46) CXCR5KDM4EGAAPOLBHPGD
SCHEMBL7677467 0.82 CA12 (0.46) CXCR5KDM4EGAAPOLBHPGD
SCHEMBL7676369 0.82 CXCR5 (0.37) CXCR5KDM4EPOLBHPGDMAPT
SCHEMBL19124992 0.81 ACHE (0.39) KDM4EGAAHPGDMAPTRAB9A
SCHEMBL4260569 0.81 CXCR5 (0.39) CXCR5KDM4EHPGDRAB9ANPC1
SCHEMBL4258057 0.81 ACHE (0.44) KDM4EGAAPOLBHPGDMAPT
SCHEMBL30995655 0.81 ACHE (0.39) KDM4EGAAHPGDMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403601-B1 TREATMENT OF ASTHMA, ANXIETY, DEPRESSION, EMESIS, URINARY INCONTINENCE AND RELATED CONDITIONS. ASTRAZENECA AB (SE) 2002-06-11 US disclosed
EP-1137637-A1 N-(2-PHENYL-4-PIPERIDINYLBUTYL)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENECARBOXAMIDES AND THEIR USE AS NEUROKININ 1 (NK1) AND/OR NEUROKININ 2 (NK2) RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-10-04 EP disclosed
WO-2000034243-A1 N-(2-PHENYL-4-PIPERIDINYBUTYL)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENECARBOXAMIDES AND THEIR USE AS NEUROKININ 1 (NK1) AND/OR NEUROKININ 2 (NK2) RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-06-15 WO disclosed